Ventricular Assist Devices (VAD)

This channel includes news and new technology innovations for Ventricular Assist Devices (VAD). VADs are a type of hemodynamic support device that helps increase blood flow in people who have ventricles that don't work properly.

Abiomed Showcases Expanded FDA Indications, Next-Generation Heart Recovery Products at TCT 2018
News | Hemodynamic Support Devices | September 20, 2018

September 19, 2018 — Abiomed Inc. announces its initiatives at the 30th Transcatheter Cardiovascular Therapeutics (...

Sponsored Content | Videos | Cath Lab | September 19, 2018

William O’Neill, M.D., outlines his recent clinical publication of AMICS patients from the Impella Quality (IQ)...

Videos | Hemodynamic Support Devices | August 31, 2018

Behnam Tehrani, M.D., FSCAI, director of the cardiac cath lab, INOVA Heart and Vascular Institute, Fairfax, Va.,...

Medtronic Receives FDA Approval for Less-Invasive Heart Pump Implant Procedure
Technology | Ventricular Assist Devices (VAD) | July 17, 2018

July 17, 2018 — Medtronic plc recently received U.S. Food and Drug Administration (FDA) approval for a less-invasive...

CorWave's Next-generation Neptune LVAD Receives Funding

Image courtesy of CorWave

News | Ventricular Assist Devices (VAD) | July 11, 2018

July 11, 2018 — French-based CorWave announced that its CALYPSO program has received 14 million euros to develop...

Two versions of the Abiomed Impella percutaneous ventricular assist device being shown at ACC 2018. Impella is the only device currently cleared by the FDA for use in cardiogenic shock.

Two versions of the Abiomed Impella percutaneous ventricular assist device displayed at ACC 2018. Impella is the only device that currently has a FDA indication for use in cardiogenic shock. 

Feature | Hemodynamic Support Devices | July 08, 2018 | Emmanouil S. Brilakis, M.D., Ph.D., FSCAI and Srihari S. Naidu, M.D., FSCAI
Cardiogenic shock (CS) is a low-cardiac-output state resulting in life-threatening end-organ hypoperfusion and hypoxia...
William O'Neill, M.D., unveils the Detroit Cardiogenic Shock Initiative at Henry Ford Hospital. The program uses new protocols to reduce cardiogenic shock mortality by 50 percent by using early hemodyanmic support.

William O'Neill, M.D., unveils the Detroit Cardiogenic Shock Initiative at Henry Ford Hospital. The program uses new protocols to reduce cardiogenic shock mortality by 50 percent by using early hemodyanmic support. 

Feature | Hemodynamic Support Devices | June 22, 2018 | Dave Fornell, Editor

About 50 percent of patients in cardiogenic shock do not survive, and account for about 90,000 heart attack patients...

The Medtronic HeartWare Ventricular Assist Devices (HVAD) has a Class I FDA recall.
Feature | Ventricular Assist Devices (VAD) | June 04, 2018

June 4, 2018 — The U.S. Food and Drug Administration said Medtronic initiated a Class 1 recall all 204,017 of its...

Abbott Recalls the HeartMate 3 Left Ventricular Assist System, LVAD
News | Ventricular Assist Devices (VAD) | May 23, 2018

May 23, 2018 — Abbott has initiated a Class I recall of the HeartMate 3...

FDA Approves Abiomed Impella CP With SmartAssist and Optical Sensor
Technology | Ventricular Assist Devices (VAD) | April 02, 2018

April 2, 2018 — Abiomed Inc. announced that it received U.S. Food and Drug Administration (FDA) Pre-Market Approval...

Videos | Heart Failure | March 23, 2018

David Lanfear M.D., FACC, head of advanced heart failure and cardiac transplantation, Henry Ford Hospital, Detroit,...

Reduced Device Clotting, Decreased Strokes Seen With HeartMate 3 at Two Years
News | Ventricular Assist Devices (VAD) | March 13, 2018

March 13, 2018 — At two years of follow-up, severely ill patients with advanced...

Abiomed Receives Expanded Impella Approval for Cardiomyopathy With Cardiogenic Shock
News | Hemodynamic Support Devices | February 15, 2018

February 15, 2018 — Abiomed Inc. announced that it received an expanded U.S. Food and Drug Administration (FDA) Pre-...

Abiomed Impella percutaneous ventricular assist device (pVAD) heart pump gains FDA PMA for high risk PCI.
Feature | Hemodynamic Support Devices | February 14, 2018

February 14, 2018 — Abiomed Inc. announced it received an expanded U.S. Food and Drug Administration (FDA) pre-...

Overlay Init